New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance

  04 December 2019

11 European partners today announced that they are launching a new project, The Collaboration for Prevention and Treatment of Multi-Drug Resistant Bacterial Infections (COMBINE), under the IMI AMR Accelerator Programme. COMBINE will support projects in the AMR Accelerator with effective management, communication, and data capture capabilities, and carry out research to strengthen the scientific basis in the AMR field. COMBINE is funded by IMI, a joint initiative between the European Commission (EC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA). COMBINE receives EUR 8 million from the EC; EFPIA in-kind contributions total EUR 17 million. 

Source: COMBINE
Author(s): COMBINE
Smart Innovations  
Back


Display your AMR technology / product:

Global AMR Technologies Database

  • Preventive – Diagnostic – Antimicrobial technologies
  • Academia – Research Institutes – Start ups – SMEs – Multinationals
  • Early research <-> near market (max 5)
  • Global reach for funding / co-development / licensing
  • No costs (until year end 2019)

Festive Launch Database 19 Nov Symposium Dinner ‘Emerging Antimicrobials and Diagnostics in AMR 2019
Click to join the Symposium Dinner (to join the Symposium separate registration obligatory)

Display your technology >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!